2024 年尿失禁全球市場報告
市場調查報告書
商品編碼
1415693

2024 年尿失禁全球市場報告

Urinary Incontinence Global Market Report 2024

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,尿失禁市場規模一直強勁成長。將從2023年的116.1億美元成長到2024年的125.2億美元,複合年成長率為7.8%。業績期間的成長是由於人口老化、尿失禁意識增強、尿失禁普及增加、獲得醫療保健的機會增加以及可支配收入增加。

預計未來幾年尿失禁市場規模將強勁成長。 2028年,這一數字將以6.6%的複合年成長率成長至161.9億美元。預測期內的成長歸因於合併症盛行率的增加、生活方式因素、人口健康策略和醫療保健支出的增加。預測期內的主要趨勢包括醫療進步、創新技術、非侵入性治療、數位健康和​​行動醫療、創新產品設計以及以患者為中心的護理。

泌尿系統疾病的日益普及將在不久的將來極大地推動尿失禁市場的擴張。泌尿系統疾病包括影響泌尿器官系統和男性生殖器官的各種疾病,包括腎臟、膀胱、輸尿管、尿道、前列腺和睪丸等重要組成部分。泌尿器官系統疾病的盛行率迅速增加,特別是尿失禁等疾病,正在推動對旨在解決這些醫療保健問題的產品和治療方案的需求。人們對泌尿系統疾病的認知和診斷不斷提高,以及醫療解決方案和醫療保健基礎設施的持續發展,進一步推動了該市場的成長。例如,美國癌症協會報告的2023年1月最新資料顯示,預計2023年美國泌尿系統癌病例數將達到82,290例,創2020年歷史新高。佔報告的 81,400 例病例的 1.1%。這證實了尿失禁市場擴張的成長勢頭,這主要是由於泌尿系統疾病的盛行率不斷上升。

對微創手術的需求不斷成長預計將在短期內推動尿失禁市場的成長。微創手術包括手術技術和干涉措施,涉及使用專用儀器和先進技術來減少手術期間所需切口的大小和數量。對此類微創手術不斷成長的需求在尿失禁的治療中發揮著重要作用,提供了一種有效且對患者友好的治療方法。患者和醫療保健提供者擴大轉向這些方法來管理症狀,同時對患者的日常生活和整體健康影響最小。例如,截至 2023 年 1 月,美國機器人產品製造商 Intuitive Surgical Inc. 報告稱,2022 年使用 Vinci 手術系統進行了約 1,875,000 例外科手術。與 2021 年使用 Vinci 手術系統進行的約 1,594,000 例手術相比,這一數字成長了 18%,令人印象深刻。因此,微創手術需求的不斷成長預計將成為支持尿失禁市場成長的關鍵驅動力。

2023年尿失禁市場最大的地區是北美。尿失禁報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美和中東/非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長,2023-2028、2033

第6章市場區隔

  • 全球尿失禁市場,按類型、實際和預測細分,2018-2023、2023-2028、2033
  • 急迫性尿失禁
  • 應力性尿失禁
  • 溢流性尿失禁
  • 功能性失禁
  • 全球尿失禁市場,依治療類型、績效及預測細分,2018-2023、2023-2028、2033
  • 藥品
  • 裝置
  • 其他
  • 全球尿失禁市場,依給藥途徑細分、績效與預測,2018-2023、2023-2028、2033
  • 口服
  • 胃腸外的
  • 其他
  • 全球尿失禁市場,依診斷、效能及預測細分,2018-2023、2023-2028、2033
  • 體檢
  • 墊片測試
  • 動態檢查
  • 膀胱鏡檢查
  • 壓力測試
  • 超音波
  • 尿液樣本
  • 全球尿失禁市場,依最終用戶細分,實際與預測,2018-2023、2023-2028、2033
  • 醫院
  • 專科診所
  • 物質照顧
  • 其他

第 7 章 區域與國家分析

  • 全球尿失禁市場,按地區、績效及預測,2018-2023、2023-2028、2033
  • 全球尿失禁市場,依國家、實際及預測,2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 尿失禁市場競爭形勢
  • 尿失禁市場公司概況
    • Cardinal Health Inc.
    • Johnson and Johnson
    • Medtronic plc
    • Eli Lilly and Company
    • Asahi Kasei Corporation

第31章 其他重大及創新企業

  • Becton Dickinson and Company (CR Bard Inc.)
  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Inc.
  • Boston Scientific Corporation
  • Mylan NV
  • Sun Pharmaceutical Industries Ltd.
  • Domtar Corporation
  • Cook Medical Inc.
  • Aurobindo Pharma Ltd
  • Coloplast AIS
  • Teleflex Incorporated
  • Apotex Inc.
  • Zydus Lifesciences Limited
  • ConvaTec Group PLC
  • Cook Group Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r12292

“Urinary Incontinence Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urinary incontinence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for urinary incontinence? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The urinary incontinence market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Urge Incontinence; Stress Incontinence; Overflow Incontinence; Functional Incontinence
  • 2) By Treatment Type: Medication; Devices; Other Treatments
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
  • 4) By Diagnosis: Physical Exam; Pad Test; Urodynamic Testing; Cystoscopy; Stress Test; Ultrasound; Urine Samples
  • 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson; Medtronic plc; Eli Lilly and Company; Asahi Kasei Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Urinary incontinence is a medical condition characterized by the involuntary loss of urine, which can range from occasional leaks to a complete inability to control urination. This condition can be caused by various factors, including weakened pelvic floor muscles, hormonal changes, obesity, neurological conditions, urinary tract infections, certain medications, and pregnancy.

The primary categories of urinary incontinence include urge incontinence, stress incontinence, overflow incontinence, and functional incontinence. Urge incontinence, also known as overactive bladder, is typified by a sudden and intense urge to urinate that is difficult to control. This type is typically managed through medications that help calm and control bladder muscles, along with behavioral techniques such as bladder training and lifestyle adjustments. Various treatments, including medications and medical devices, are administered through oral, parenteral, and other routes to address urinary incontinence. Diagnostic tools and services, such as physical examinations, pad tests, urodynamic testing, cystoscopy, stress tests, ultrasound scans, and urine samples, are provided by a range of end users, including hospitals, specialty clinics, homecare services, and others.

The urinary incontinence market research report is one of a series of new reports from The Business Research Company that provides urinary incontinence market statistics, including urinary incontinence industry global market size, regional shares, competitors with a urinary incontinence market share, detailed urinary incontinence market segments, market trends and opportunities and any further data you may need to thrive in the urinary incontinence industry. This urinary incontinence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinary incontinence market size has grown strongly in recent years. It will grow from $11.61 billion in 2023 to $12.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to aging population, awareness of urinary incontinence, rising prevalence of urinary incontinence, increasing access to healthcare, rising disposable incomes.

The urinary incontinence market size is expected to see strong growth in the next few years. It will grow to $16.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of comorbidities, lifestyle factors, population health strategies, growing healthcare expenditures. Major trends in the forecast period include medical advancements, innovative technologies, non-invasive treatments, digital health and mhealth, innovative product designs, patient-centered care.

The increasing prevalence of urological disorders is set to provide significant impetus to the expansion of the urinary incontinence market in the near future. Urological disorders encompass a wide array of medical conditions affecting the urinary system and male reproductive organs, which includes critical components like the kidneys, bladder, ureters, urethra, prostate, and testes. This upsurge in the prevalence of urological disorders, with a particular emphasis on conditions like urinary incontinence, is driving the demand for products and treatment options designed to address these healthcare concerns. The rising awareness and diagnosis of urological disorders, in conjunction with ongoing developments in medical solutions and healthcare infrastructure, are further bolstering the growth of this market. For instance, recent data from January 2023, as reported by the American Cancer Society Inc., reveals that the estimated cases of urinary bladder cancer in the United States have reached 82,290 in 2023, signifying a 1.1% increase from the 81,400 cases recorded in 2020. This underscores the momentum behind the expansion of the urinary incontinence market, primarily driven by the growing incidence of urological disorders.

The increasing demand for minimally invasive procedures is anticipated to be a driving force for the growth of the urinary incontinence market in the foreseeable future. Minimally invasive procedures encompass surgical techniques and interventions that involve the utilization of specialized instruments and advanced technology to reduce the size and quantity of incisions required during surgery. This heightened demand for minimally invasive procedures plays a crucial role in managing urinary incontinence, offering an effective and patient-friendly approach to its treatment. Patients and healthcare providers are increasingly opting for these methods to address the condition while minimizing the impact on a patient's daily life and overall well-being. For instance, as of January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicate that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This reflects an impressive 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the mounting demand for minimally invasive procedures is set to be a significant driver behind the growth of the urinary incontinence market.

The main challenge hindering the growth of the urinary incontinence market during the forecast period is the limited accessibility of effective mechanical devices for urinary incontinence. This restricted availability of reliable mechanical devices for urinary incontinence proves to be a significant impediment in the market. It can lead to a lower number of individuals seeking treatment and can result in dissatisfaction with treatment outcomes. For instance, a Health Affairs article from 2021 reported that the United States experienced at least one shortage of medical devices each year, with the highest frequency occurring in 2020. Consequently, the limited accessibility of effective mechanical devices for urinary incontinence is constraining the expansion of the urinary incontinence market.

Prominent companies within the urinary incontinence market are proactively adopting cutting-edge technologies and groundbreaking approaches to elevate patient care and enhance treatment outcomes. For instance, in July 2023, UroMems SAS, a biotechnology firm based in France, successfully carried out the implantation of the UroActive smart artificial urinary sphincter (AUS) in a female patient for the treatment of stress urinary incontinence (SUI) in women. This groundbreaking UroActive device is powered by a myoelectrical mechanical system (MEMS) meticulously engineered to address the unmet need for a definitive SUI treatment in women. The procedure was conducted with robotic assistance at La Pitie-Salpetriere University Hospital in Paris and garnered regulatory approval from the French equivalent of the FDA. UroActive's adaptability, intelligent functionality, and minimally invasive approach collectively aim to enhance the quality of life for patients.

In February 2021, Axonics Modulation Technologies, Inc., a US-based medical equipment manufacturing company, acquired Contura Ltd. for $200 million. The acquisition of Contura Ltd. allowed Axonics Modulation Technologies to expand its offerings, enhance its value proposition to customers and leverage its existing commercial footprint to address the underpenetrated stress urinary incontinence (SUI) market with a clinically differentiated solution. Contura Ltd. is a UK-based medical technology company specializing in developing urinary health treatment products.

Major players in the urinary incontinence market are Cardinal Health Inc., Johnson and Johnson, Medtronic PLC, Eli Lilly and Company, Asahi Kasei Corporation, Becton Dickinson and Company (C.R. Bard Inc.), Teva Pharmaceutical Industries Ltd., Berry Global Inc., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Domtar Corporation, Cook Medical Inc., Aurobindo Pharma Ltd., Coloplast AIS, Teleflex Incorporated, Apotex Inc., Zydus Lifesciences Limited, ConvaTec Group PLC, Cook Group Inc., Torrent Pharmaceuticals Ltd., Alennbic Pharmaceuticals Limited, Laborie Medical Technologies Corp., NeoTract Inc., Ethicon Inc., Promedon GmbH, Caldera Medical Inc .

North America was the largest region in the urinary incontinence market in 2023. The regions covered in urinary incontinence report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urinary incontinence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urinary incontinence market includes revenues earned by entities by providing medical diagnosis and evaluation, medication and surgical interventions, pelvic floor muscle training and physical therapy, behavioral therapies and bladder training and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinary incontinence market also includes sales of electrical stimulation devices, foley catheters, antimicrobial foley catheters and urethral bulking agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Urinary Incontinence Market Characteristics

3. Urinary Incontinence Market Trends And Strategies

4. Urinary Incontinence Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Urinary Incontinence Market Size and Growth

  • 5.1. Global Urinary Incontinence Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Urinary Incontinence Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Urinary Incontinence Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Urinary Incontinence Market Segmentation

  • 6.1. Global Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Urge Incontinence
  • Stress Incontinence
  • Overflow Incontinence
  • Functional Incontinence
  • 6.2. Global Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Devices
  • Other Treatments
  • 6.3. Global Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administrations
  • 6.4. Global Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Physical Exam
  • Pad Test
  • Urodynamic Testing
  • Cystoscopy
  • Stress Test
  • Ultrasound
  • Urine Samples
  • 6.5. Global Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Urinary Incontinence Market Regional And Country Analysis

  • 7.1. Global Urinary Incontinence Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Urinary Incontinence Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Urinary Incontinence Market

  • 8.1. Asia-Pacific Urinary Incontinence Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Urinary Incontinence Market

  • 9.1. China Urinary Incontinence Market Overview
  • 9.2. China Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Urinary Incontinence Market

  • 10.1. India Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Urinary Incontinence Market

  • 11.1. Japan Urinary Incontinence Market Overview
  • 11.2. Japan Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Urinary Incontinence Market

  • 12.1. Australia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Urinary Incontinence Market

  • 13.1. Indonesia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Urinary Incontinence Market

  • 14.1. South Korea Urinary Incontinence Market Overview
  • 14.2. South Korea Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Urinary Incontinence Market

  • 15.1. Western Europe Urinary Incontinence Market Overview
  • 15.2. Western Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Urinary Incontinence Market

  • 16.1. UK Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Urinary Incontinence Market

  • 17.1. Germany Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Urinary Incontinence Market

  • 18.1. France Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Urinary Incontinence Market

  • 19.1. Italy Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Urinary Incontinence Market

  • 20.1. Spain Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Urinary Incontinence Market

  • 21.1. Eastern Europe Urinary Incontinence Market Overview
  • 21.2. Eastern Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Urinary Incontinence Market

  • 22.1. Russia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Urinary Incontinence Market

  • 23.1. North America Urinary Incontinence Market Overview
  • 23.2. North America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Urinary Incontinence Market

  • 24.1. USA Urinary Incontinence Market Overview
  • 24.2. USA Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Urinary Incontinence Market

  • 25.1. Canada Urinary Incontinence Market Overview
  • 25.2. Canada Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Urinary Incontinence Market

  • 26.1. South America Urinary Incontinence Market Overview
  • 26.2. South America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Urinary Incontinence Market

  • 27.1. Brazil Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Urinary Incontinence Market

  • 28.1. Middle East Urinary Incontinence Market Overview
  • 28.2. Middle East Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Urinary Incontinence Market

  • 29.1. Africa Urinary Incontinence Market Overview
  • 29.2. Africa Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Urinary Incontinence Market Competitive Landscape And Company Profiles

  • 30.1. Urinary Incontinence Market Competitive Landscape
  • 30.2. Urinary Incontinence Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eli Lilly and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Asahi Kasei Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Urinary Incontinence Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (C.R. Bard Inc.)
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Berry Global Inc.
  • 31.4. Boston Scientific Corporation
  • 31.5. Mylan N.V.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Domtar Corporation
  • 31.8. Cook Medical Inc.
  • 31.9. Aurobindo Pharma Ltd
  • 31.10. Coloplast AIS
  • 31.11. Teleflex Incorporated
  • 31.12. Apotex Inc.
  • 31.13. Zydus Lifesciences Limited
  • 31.14. ConvaTec Group PLC
  • 31.15. Cook Group Inc.

32. Global Urinary Incontinence Market Competitive Benchmarking

33. Global Urinary Incontinence Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Urinary Incontinence Market

35. Urinary Incontinence Market Future Outlook and Potential Analysis

  • 35.1 Urinary Incontinence Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Urinary Incontinence Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Urinary Incontinence Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer